本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

7.04
+0.08001.15%
盤後7.040.00000.00%16:10 EDT
成交量:5.79萬
成交額:40.93萬
市值:4,356.21萬
市盈率:-2.87
高:7.36
開:7.06
低:6.82
收:6.96
52周最高:13.69
52周最低:3.76
股本:618.78萬
流通股本:300.20萬
量比:1.44
換手率:1.93%
股息:- -
股息率:- -
每股收益(TTM):-2.4500
每股收益(LYR):-2.4500
淨資產收益率:-196.92%
總資產收益率:-69.33%
市淨率:0.81
市盈率(LYR):-2.87

資料載入中...

2024/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/25

重要事件披露

Form 8-K - Current report
2023/11/23

SEC問詢函

Form CORRESP - Correspondence
2023/11/23

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/06

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]